---
title: "AGS released its semi-annual performance report, with a net profit attributable to the parent company of 126 million yuan, a year-on-year increase of 1.26%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252030630.md"
description: "AGS released its semi-annual performance for 2025, with revenue of 302 million yuan, a year-on-year increase of 14.56%; net profit attributable to shareholders of 126 million yuan, a year-on-year increase of 1.26%; net profit excluding non-recurring items of 112 million yuan, a year-on-year decrease of 7.06%; basic earnings per share of 1.5562 yuan. The change in net cash flow is mainly due to a decrease in interest income and an increase in R&D personnel and employee compensation"
datetime: "2025-08-07T11:56:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252030630.md)
  - [en](https://longbridge.com/en/news/252030630.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252030630.md)
---

# AGS released its semi-annual performance report, with a net profit attributable to the parent company of 126 million yuan, a year-on-year increase of 1.26%

According to the Zhitong Finance APP, AGS (688581.SH) disclosed its semi-annual report for 2025, reporting revenue of 302 million yuan, a year-on-year increase of 14.56%; net profit attributable to shareholders of the listed company was 126 million yuan, a year-on-year increase of 1.26%; net profit excluding non-recurring gains and losses was 112 million yuan, a year-on-year decrease of 7.06%; basic earnings per share were 1.5562 yuan.

Explanation of the reasons for the change in net cash flow from operating activities: mainly due to a decrease in interest income and an increase in R&D personnel, resulting in higher compensation paid to employees

### Related Stocks

- [688581.CN](https://longbridge.com/en/quote/688581.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [Russia plans to return staff to Iranian Bushehr nuclear plant in coming weeks, RIA reports](https://longbridge.com/en/news/286905394.md)
- [Mabwell Wins Wider China Indications for Denosumab Biosimilar as Global Push Accelerates](https://longbridge.com/en/news/287103520.md)
- [13:41 ETUT Haslam Marks Decade in Major International Ranking's Top Five U.S. Public Schools](https://longbridge.com/en/news/286804132.md)
- [Allen & Heath Rolls Out New SQ+ Lineup of Digital Mixers Announced; First Look YouTube Video on SQ5+,   SQ6+, and   SQ7+ Digital Mixers at B&H](https://longbridge.com/en/news/287101198.md)